Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
The Antibody Registry is the authoritative source for antibody identifiers, which can be used in publications to uniquely mark the antibodies used in a paper.
| Antibody Name | Proper Citation | Target Antigen | Target Organism |
Clone ID |
Defining Citation |
Comments |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Anti-Human HER-2 (Trastuzumab) - Fc Muted™ Resource Report Resource Website |
Leinco Technologies Cat# LT1505, RRID:AB_2893915 | HER-2/neu | human | clone: 4D5-8 |
Applications: CyTOF®, ELISA, FC, IHC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Trastuzumab. Clone 4D5-8 recognizes human erbB-2. This product is for research use only. |
recombinant monoclonal | human | AB_2893915 | Leinco Technologies | LT1505 | 2026-08-31 11:33:20 | 0 | |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-C5) - Biotin Resource Report Resource Website |
Leinco Technologies Cat# LT7031, RRID:AB_2893992 | SARS-CoV-2 Nucleocapsid (N) | Virus, SARS-CoV-2 | clone: NP1-B9 |
Applications: ELISA Info: Anti-SARS-CoV-2 Nucleocapsid, clone NP1-C5, specifically targets an epitope on the SARS-CoV-2 nucleocapsid protein. Furthermore, it is reported to bind to the RNA binding domain of the N protein. |
recombinant monoclonal | mouse | AB_2893992 | Leinco Technologies | LT7031 | 2026-08-28 06:11:33 | 0 | |
|
Anti-Human CTLA-4 (Ipilimumab) - Fc Muted™ Biotin Resource Report Resource Website |
Leinco Technologies Cat# LT1606, RRID:AB_2893923 | CTLA-4 | human | clone: MDX-010 |
Applications: ELISA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Ipilimumab. Ipilimumab binds to Human CTLA-4. This product is for research use only. |
recombinant monoclonal | human | AB_2893923 | Leinco Technologies | LT1606 | 2026-08-29 01:30:48 | 0 | |
|
Anti-Human CD194 (CCR4) (Mogamulizumab) - Fc Muted™ Resource Report Resource Website |
Leinco Technologies Cat# LT1005, RRID:AB_2893877 | CD194 | human | clone: KW-0761 |
Applications: Depletion, ELISA, FA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Mogamulizumab. Clone KW-0761 recognizes human CD194 (CCR4). This product is for research use only. |
recombinant monoclonal | human | AB_2893877 | Leinco Technologies | LT1005 | 2026-08-31 01:24:58 | 0 | |
|
Anti-Human CD52 (Alemtuzumab) - Biotin Resource Report Resource Website |
Leinco Technologies Cat# LT201, RRID:AB_2893938 | CD52 | Human, Rhesus Monkey, Cynomolgus Monkey | clone: Campath-1H |
Applications: ELISA, FA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Alemtuzumab. Clone Campath-1H recognizes human CD52. This product is for research use only. |
recombinant monoclonal | human | AB_2893938 | Leinco Technologies | LT201 | 2026-08-31 05:05:53 | 0 | |
|
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Dylight® 488 Resource Report Resource Website |
Leinco Technologies Cat# LT1111, RRID:AB_2893892 | CD49D | human | clone: Hu114 |
Applications: FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Natalizumab. Natalizumab binds to the alpha 4 subunit of α4β1 and α4β7 integrins. This product is for research use only. |
recombinant monoclonal | human | AB_2893892 | Leinco Technologies | LT1111 | 2026-08-29 09:41:02 | 0 | |
|
Anti-SARS-CoV-2 Spike RBD (Clone 2165) - HRP Resource Report Resource Website |
Leinco Technologies Cat# LT1910, RRID:AB_2893934 | SARS-CoV-2 RBD | Virus, SARS-CoV-2 | clone: 2165 |
Applications: ELISA, IHC Info: Anti-SARS-CoV-2 Spike RBD-HRP, clone 2165, specifically targets an epitope on the SARS-CoV-2 spike protein receptor-binding domain (RBD). |
recombinant monoclonal | AB_2893934 | Leinco Technologies | LT1910 | 2026-08-31 08:00:09 | 0 | ||
|
Anti-Human IL-2R alpha (CD25) (Basiliximab) - Fc Muted™ Resource Report Resource Website |
Leinco Technologies Cat# LT305, RRID:AB_2893951 | CD25 | Human, Rhesus Monkey, Cynomolgus Monkey | clone: Hu107 |
Applications: B, CyTOF®, FC, IF, IHC, WB Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Basiliximab. Basiliximab recognizes human CD25. This product is for research use only. |
recombinant monoclonal | human | AB_2893951 | Leinco Technologies | LT305 | 2026-08-29 04:11:36 | 0 | |
|
Anti-Human VEGF (Bevacizumab) - Fc Muted™ Biotin Resource Report Resource Website |
Leinco Technologies Cat# LT406, RRID:AB_2893959 | VEGF | human | clone: A4.6.1 |
Applications: ELISA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Bevacizumab. Bevacizumab recognizes both native and reduced human VEGF (isoform 165). This product is for research use only. |
recombinant monoclonal | human | AB_2893959 | Leinco Technologies | LT406 | 2026-08-29 08:50:29 | 0 | |
|
Anti-Human TNF alpha (Adalimumab) - Fc Muted™ HRP Resource Report Resource Website |
Leinco Technologies Cat# LT107, RRID:AB_2893886 | TNF alpha | human | clone: D2E7 |
Applications: ELISA, FA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Adalimumab. Clone D2E7 binds to soluble TNF- α, but not to TNF- β (lymphotoxin). This product is for research use only. |
recombinant monoclonal | human | AB_2893886 | Leinco Technologies | LT107 | 2026-08-29 10:41:04 | 0 | |
|
Anti-Human TNF alpha (Adalimumab) Resource Report Resource Website |
Leinco Technologies Cat# LT100, RRID:AB_2893873 | TNF alpha | human | clone: D2C5-Ky82 |
Applications: B, ELISA, FA, FC, IF, IHC, IP, N Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Adalimumab. Clone D2E7 binds to soluble TNF- α, but not to TNF- β (lymphotoxin). This product is for research use only. |
recombinant monoclonal | human | AB_2893873 | Leinco Technologies | LT100 | 2026-08-28 04:54:56 | 0 | |
|
Anti-Human CD257 (BAFF) (Tabalumab) - Biotin Resource Report Resource Website |
Leinco Technologies Cat# LT1401, RRID:AB_2893904 | BAFF | Human, Rabbit, Cynomolgus Monkey | clone: Tabalumab |
Applications: ELISA, FA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Tabalumab. Tabalumab neutralizes soluble human, cynomolgus monkey, and rabbit BAFF. Additionally, Tabalumab neutralizes membrane-bound BAFF. This product is for research use only. |
recombinant monoclonal | human | AB_2893904 | Leinco Technologies | LT1401 | 2026-08-31 09:58:27 | 0 | |
|
Anti-Human CTLA-4 (Ipilimumab) - Biotin Resource Report Resource Website |
Leinco Technologies Cat# LT1601, RRID:AB_2893920 | CTLA-4 | human | clone: MDX-010 |
Applications: ELISA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Ipilimumab. Ipilimumab binds to Human CTLA-4. This product is for research use only. |
recombinant monoclonal | human | AB_2893920 | Leinco Technologies | LT1601 | 2026-08-29 05:06:04 | 0 | |
|
Anti-Human CD194 (CCR4) (Mogamulizumab) - HRP Resource Report Resource Website |
Leinco Technologies Cat# LT1002, RRID:AB_2893876 | CD194 | human | clone: KW-0761 |
Applications: Depletion, ELISA, FA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Mogamulizumab. Clone KW-0761 recognizes human CD194 (CCR4). This product is for research use only. |
recombinant monoclonal | human | AB_2893876 | Leinco Technologies | LT1002 | 2026-08-31 03:43:48 | 0 | |
|
Anti-SARS-CoV-2 Spike NTD (Clone 2146) - Biotin Resource Report Resource Website |
Leinco Technologies Cat# LT2005, RRID:AB_2893937 | SARS-CoV-2 Spike NTD | Virus, SARS-CoV-2 | clone: 2146 |
Applications: ELISA, IHC Info: Anti-SARS-CoV-2 Spike NTD-Biotin, clone 2146, specifically targets an epitope on the SARS-CoV-2 spike protein N-terminal domain. |
recombinant monoclonal | AB_2893937 | Leinco Technologies | LT2005 | 2026-08-31 09:58:27 | 0 | ||
|
Anti-Human CD11a (Efalizumab) - HRP Resource Report Resource Website |
Leinco Technologies Cat# LT802, RRID:AB_2894022 | CD11a | human | clone: hu1124 |
Applications: ELISA, FA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Efalizumab. Clone hu1124 recognizes human CD11a. This product is for research use only. |
recombinant monoclonal | human | AB_2894022 | Leinco Technologies | LT802 | 2026-08-31 09:58:27 | 0 | |
|
Anti-Human CD52 (Alemtuzumab) - Fc Muted™ HRP Resource Report Resource Website 1+ mentions |
Leinco Technologies Cat# LT207, RRID:AB_2893945 | CD52 | Human, Rhesus Monkey, Cynomolgus Monkey | clone: Campath-1H |
Applications: ELISA, FA, FC Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Alemtuzumab. Clone Campath-1H recognizes human CD52. This product is for research use only. |
recombinant monoclonal | human | AB_2893945 | Leinco Technologies | LT207 | 2026-08-28 04:03:46 | 1 | |
|
Anti-SARS-CoV-2 Nucleocapsid (N) Resource Report Resource Website 1+ mentions |
Leinco Technologies Cat# LT7000, RRID:AB_2893978 | SARS-CoV-2 Nucleocapsid (N) | Virus, SARS-CoV-2 | clone: 1A8 |
Applications: ELISA, IHC, WB Info: Anti-SARS-CoV-2 Nucleocapsid, clone 1C7C7, specifically targets an epitope on the SARS-CoV-2 nucleocapsid protein. |
recombinant monoclonal | AB_2893978 | Leinco Technologies | LT7000 | 2026-08-31 12:29:18 | 1 | ||
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-D4) - Biotin Resource Report Resource Website 1+ mentions |
Leinco Technologies Cat# LT7061, RRID:AB_2894004 | SARS-CoV-2 Nucleocapsid (N) | Virus, SARS-CoV-2 | clone: NP1-D4 |
Applications: ELISA Info: Anti-SARS-CoV-2 Nucleocapsid, clone NP1-D4, specifically targets an epitope on the SARS-CoV-2 nucleocapsid protein. Furthermore, it is reported to bind to the RNA binding domain of the N protein. |
recombinant monoclonal | mouse | AB_2894004 | Leinco Technologies | LT7061 | 2026-08-31 09:09:34 | 1 | |
|
Anti-Human CD257 (BAFF) (Tabalumab) - Dylight® 488 Resource Report Resource Website |
Leinco Technologies Cat# LT1411, RRID:AB_2893909 | BAFF | Human, Rabbit, Cynomolgus Monkey | clone: Tabalumab |
Applications: FA, FC, IF Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Tabalumab. Tabalumab neutralizes soluble human, cynomolgus monkey, and rabbit BAFF. Additionally, Tabalumab neutralizes membrane-bound BAFF. This product is for research use only. |
recombinant monoclonal | human | AB_2893909 | Leinco Technologies | LT1411 | 2026-08-31 05:05:53 | 0 |
Can't find your Antibody?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific antibody, it's easier to enter an RRID or a Catalog Number to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your antibody in the search results, please help us by registering it into the system — it's easy. Register it with The Antibody Registry (an Antibody Registry account is required. Create a free Antibody Registry account if you don't have one yet). An RRID will be generated in 1-2 business days.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
